Thistledown Capital

Marvel Fusion is a Munich-based company established in 2019 that specializes in the development of fusion energy technology. The company focuses on creating a laser-based nuclear fusion reactor designed to provide environmentally friendly and safe energy solutions. Its innovative reactor utilizes short pulse, high energy, and electrically efficient lasers, making it suitable for the commercialization of baseload fusion electrical power. By advancing this technology, Marvel Fusion aims to enable consumers to access clean, reliable energy sources, contributing to a sustainable energy future.

Loam Bio is a company focused on manufacturing microbial products designed to reduce atmospheric CO2 levels and enhance soil fertility. Founded in 2016 and based in Orange, Australia, the company is engaged in developing innovative technology that enables the inoculation of crops with symbiotic micro-organisms. This approach aims to improve agricultural sustainability by promoting healthier soils and more efficient carbon management.

General Fusion Inc., established in 2002 and headquartered in Burnaby, Canada, specializes in developing commercial Magnetized Target Fusion (MTF), a hybrid fusion method combining magnetic confinement and inertial confinement principles. The company focuses on creating utility-scale fusion power using its patent-pending MTF concept, which has the potential to provide clean, safe, and economical energy. General Fusion develops key subsystems such as plasma injectors, acoustic drivers, and liquid metal vortex compression tests to advance its MTF technology. Backed by a global syndicate of investors, industry leaders, and technology pioneers, General Fusion aims to demonstrate and commercialize its innovative fusion power plants by the end of the decade.

CarbonCure Technologies Inc. is a Canadian company that specializes in technology designed to sequester carbon dioxide (CO2) in concrete production. Founded in 2007 and headquartered in Dartmouth, Nova Scotia, the company provides a retrofit solution for existing concrete plants, allowing producers to incorporate waste CO2 from industrial emitters into their concrete products. During manufacturing, this CO2 is chemically converted into solid mineral carbonates, enhancing the strength of the concrete while reducing its carbon footprint. CarbonCure's innovative approach enables concrete manufacturers to produce green concrete without compromising quality or cost, thereby facilitating a shift towards sustainable building practices. The company also offers marketing and environmental reporting services to support its customers in the growing green building market. By licensing its technology at a low capital expenditure, CarbonCure generates a recurring revenue stream while contributing to the reduction of greenhouse gas emissions in the concrete industry.